EXACT Therapeutics AS (OSL:EXTX)

Norway flag Norway · Delayed Price · Currency is NOK
2.480
+0.200 (8.77%)
At close: Sep 3, 2025
8.77%
Market Cap156.89M
Revenue (ttm)n/a
Net Income (ttm)-52.33M
Shares Out63.26M
EPS (ttm)-1.51
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume16,863
Average Volume15,624
Open2.980
Previous Close2.280
Day's Range2.400 - 2.980
52-Week Range2.180 - 6.200
Beta0.14
RSI46.78
Earnings DateSep 10, 2025

About EXACT Therapeutics AS

EXACT Therapeutics AS, a clinical stage biopharmaceutical company, develops a technology platform for targeted therapeutic enhancement, Acoustic Cluster Therapy (ACT). The ACT is an approach to ultrasound-mediated, targeted drug enhancement with the potential to amplify the clinical utility of a range of therapeutic agents across various indications, including within oncology and brain diseases. The company’s ACT platform is under Phase I clinical trial for treatment of liver metastases; and pre-clinical studies for pancreatic, glioblastoma, an... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2012
Employees 12
Stock Exchange Oslo Børs
Ticker Symbol EXTX
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.